Patents
Patents for C07K 19 - Hybrid peptides (29,428)
06/1997
06/04/1997EP0776975A2 Method for use of the yeast-ADH-II promotersystem for the biotechnological production of heterologous proteins in high yield
06/04/1997EP0776972A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN
06/04/1997EP0776969A2 Process to prepare proteins by controlled proteolysis of pro-proteins
06/04/1997EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto
06/04/1997EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
06/04/1997EP0776339A1 Mhc complexes and uses thereof
06/04/1997EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells
06/03/1997US5635601 Beta-8 integrin subunit antibodies
06/03/1997US5635593 Bradykinin antagonists
06/03/1997US5635372 BMP-15 compositions
06/03/1997US5635371 Modifying dna sequence encoding recombinant polypeptide by adding sequence encoding protecting group having cleavage sequence, removing biologically added protecting group, modifying unprotected terminal amino acid, deprotecting
06/03/1997US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation
05/1997
05/29/1997WO1997019179A1 Pseudomonas exotoxin - myelin basic protein chimeric proteins
05/29/1997WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
05/29/1997CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
05/29/1997CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions
05/28/1997EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs
05/28/1997EP0775206A1 Dual hybrid system
05/28/1997EP0674734B1 Ski slope maintenance device
05/28/1997EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia
05/28/1997EP0455705B1 Receptor membranes and ionophore gating
05/27/1997US5633234 Lysosomal targeting of immunogens
05/27/1997US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c
05/22/1997WO1997018315A1 Hybrid factor viii with modified activity
05/22/1997WO1997018314A1 Process for the preparation of peptides by way of streptavidin fusion proteins
05/22/1997WO1997018309A1 E6 binding proteins
05/22/1997WO1997018233A1 Method for producing a correctly folded, biological active recombinant protein
05/22/1997WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r)
05/22/1997WO1997017988A1 Type ix collagen and chimeras
05/22/1997CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r)
05/22/1997CA2237900A1 Type ix collagen and chimeras
05/22/1997CA2237783A1 E6 binding proteins
05/22/1997CA2237299A1 Compounds and methods for the detection and prevention of t. cruzi infection
05/22/1997CA2235628A1 Hybrid factor viii with modified activity
05/21/1997EP0774511A1 Methods of producing members of specific binding pairs
05/21/1997EP0773997A2 Htk ligand
05/21/1997EP0773960A1 POLYPEPTIDES WITH Fc BINDING ABILITY
05/21/1997EP0773952A1 Interaction trap systems for detecting protein interactions
05/21/1997EP0527821B1 Oxidation resistant thrombomodulin analogs
05/21/1997CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation
05/20/1997US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor
05/20/1997US5631229 Method for inactivating gonadotrophs
05/20/1997US5631009 Erythrocytes and reaction with antisera and antibodies
05/15/1997WO1997017443A1 Huntingtin-associated protein
05/15/1997WO1997001640A3 Vaccines against hepatitis c
05/15/1997CA2237183A1 Huntingtin-associated protein
05/14/1997EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein
05/13/1997US5629408 Immunochemical isolation of in vivo advanced glycosylation endproducts
05/13/1997US5629172 Ubiquitin molecule is cleavage site
05/09/1997WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
05/09/1997CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
05/07/1997EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae
05/07/1997EP0771326A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same
05/07/1997EP0771325A1 Process for modifying the stability of antibodies
05/07/1997EP0771216A1 Methods and compositions for the specific coagulation of vasculature
05/07/1997EP0661993B1 Protection against liver damage by hgf
05/07/1997CN1149299A Anti-GP39 antibodies and uses therefor
05/07/1997CN1149258A Inhibin compositions and methods of use thereof
05/06/1997US5627267 Cytokine designated elk ligand
05/06/1997US5627264 Chimeric complement inhibitor proteins
05/02/1997EP0770874A2 Receptor membranes and ionophore gating
05/02/1997EP0770679A2 HCV-specific peptides, preparations related to them and their use
05/02/1997EP0770135A1 Novel compounds
05/02/1997EP0770088A1 Novel cytokine designated lerk-5
05/02/1997EP0627006B1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin
05/02/1997EP0594594B1 Methods of producing hybrid g protein-coupled receptors
05/01/1997WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same
05/01/1997WO1997015598A1 Novel peptide
05/01/1997WO1997015326A1 Remedy for hepatitides
05/01/1997WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES
05/01/1997CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates
04/1997
04/29/1997US5625031 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
04/29/1997US5624899 Ligands and proteins
04/29/1997US5624837 Nucleic acid encoding chimeric complement inhibitor proteins
04/29/1997US5624821 Antibodies with altered effector functions
04/29/1997US5624804 Glycosylation of protein such as albumin for medical diagnosis
04/24/1997WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
04/24/1997WO1997014796A1 Monoclonal antibody br110 and uses thereof
04/23/1997EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines
04/23/1997EP0707599B1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins
04/22/1997US5623058 Medical diagnosis; complexing using dimethylethylaminopropylcarbodiimide
04/22/1997US5623056 Immunomodulators
04/22/1997US5623051 Methods and compositions for screening for presynaptic calcium channel blockers
04/22/1997US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells
04/22/1997US5622933 Multiple branch peptide constructions for use against HIV
04/22/1997US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell
04/17/1997WO1997013856A1 Improvements in or relating to protection against intracellular infection
04/17/1997WO1997013410A1 Hybrid molecules containing amidated polypeptide binding ligands
04/17/1997CA2232155A1 Improvements in or relating to protection against intracellular infection
04/16/1997EP0768377A1 Generation and selection of recombinant varied binding proteins
04/16/1997EP0454782B1 Cancer related haptoglobin (hpr)
04/16/1997CN1034588C Improved method for man-promoting growth factor C
04/15/1997US5620958 Bradykinin antagonists
04/10/1997WO1997012988A1 Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
04/10/1997WO1997012985A2 Multi-functional hematopoietic receptor agonists
04/10/1997WO1997005250A3 Receptor ligand vegf-c
04/10/1997WO1997000319A3 Chimeric leptin fused to immunoglobulin domain and use
04/10/1997CA2234061A1 Multi-functional hematopoietic receptor agonists